Cait joined FARA in 2022 with over 10 years of industry experience in global clinical research studies, including phase I-IV drug and PMA device trials (first-in-human through post-market). Her experience encompasses perspective working in small startup, large corporate, and investigative site settings. With FARA, Cait will be responsible for leading the global effort to establish a Friedreich’s Ataxia Global Clinical Consortium (FA-GCC), ensuring that the necessary operations and infrastructure are in place to support the scientific and strategic goals of the consortium. Cait holds a Bachelor of Science in Genetics and Cellular Development from the University of Minnesota.
Director of Clinical Operations